Company profile

Exo Inc

Exo Inc has 4 AI-enabled medical devices on the FDA list. The first decision was on June 22, 2023 and the most recent on April 24, 2025 (Lung AI (LAI001)). Its most common review panel is Radiology (4 devices).

4AI devices
2023First decision
2025Latest decision
1Specialties

Per year

2023: 22024: 12025: 1
202320242025
Exo Inc AI devices per year: 2023 2, 2024 1, 2025 1

By specialty

  • Radiology4

Related guides

Timeline

  1. Lung AI (LAI001) · Radiology · MYN
  2. Strain AI (SAI001) · Radiology · QIH
  3. AI Platform (AIP001) · Radiology · QIH
  4. Bladder AI (AIBV01) · Radiology · QIH